{"database": "openregs", "table": "documents", "rows": [["FDA-2025-N-0708-0001", "FDA", "FDA-2025-N-0708", "Medical Devices; Immunology and Microbiology Devices; Classification of the DNA-Based Test To Measure\nMinimal Residual Disease in Hematological Malignancies", "Rule", "Final Rule", "2025-05-09T00:00:00Z", 2025, 5, "2025-05-09T00:00:00Z", null, "2025-05-21T19:36:21Z", "2025-08143", 0, 0, "09000064b8d1ec0d"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2025-N-0708-0001"], "units": {}, "query_ms": 0.4428070969879627, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}